A chemical with proven clinical safety restores Down syndrome-related phenotypes via DYRK1A inhibition
DYRK1A is important in neuronal development and function, and its excessive activity is considered a significant pathogenic factor in Down syndrome and Alzheimer's disease. Thus, inhibition of DYRK1A has been suggested to be a new strategy to modify the disease. Very few compounds, however, hav...
Salvato in:
Autori principali: | , , , , , , , , , , , , |
---|---|
Natura: | Artigo |
Lingua: | inglese |
Pubblicazione: |
2016
|
Accesso online: | https://doi.org/10.1242/dmm.025668 https://dmm.biologists.org/content/dmm/9/8/839.full.pdf |
Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|